TABLE 1.

Hepatitis A virus (HAV) vaccine response in persons with hepatitis C virus (HCV) infection

Author (ref), site(s)	Year published	Subjects	Vaccine schedule	Results in chronic HCV	Results in controls
Keeffe et al (14), 4 United States 4 European	1998	104 anti-HCV reactive 188 controls	1440 ELU of Havrix* 0,6 months	94% HAV scv at 7 months	98% HAV scv at 7 months

Seroconversion (scv) for anti-HAV greater than or equal to 33 mIU/mL.

^*GlaxoSmithKline, USA. ELU ELISA units; ref Reference